Body

'Unsung' cells double the benefits of a new osteoporosis drug

Experiments in mice with a bone disorder similar to that in women after menopause show that a scientifically overlooked group of cells are likely crucial to the process of bone loss caused by the disorder, according to Johns Hopkins researchers. Their discovery, they say, not only raises the research profile of the cells, called preosteoclasts, but also explains the success and activity of an experimental osteoporosis drug with promising results in phase III clinical trials.

A summary of their work will be published on Oct. 5 in the journal Nature Medicine.

GIANT study reveals giant number of genes linked to height

The largest genome-wide association study (GWAS) to date, involving more than 300 institutions and more than 250,000 subjects, roughly doubles the number of known gene regions influencing height to more than 400. The study, from the international Genetic Investigation of Anthropometric Traits (GIANT) Consortium, provides a better glimpse at the biology of height and offers a model for investigating traits and diseases caused by many common gene changes acting together. Findings were published online October 5 by Nature Genetics.

Scientists develop barcoding tool for stem cells

A 7-year-project to develop a barcoding and tracking system for tissue stem cells has revealed previously unrecognized features of normal blood production: New data from Harvard Stem Cell Institute scientists at Boston Children's Hospital suggests, surprisingly, that the billions of blood cells that we produce each day are made not by blood stem cells, but rather their less pluripotent descendants, called progenitor cells.

Discovery of a novel heart and gut disease

This news release is available in French and German.

'Programmable' antibiotic harnesses an enzyme to attack drug-resistant microbes

The multitude of microbes scientists have found populating the human body have good, bad and mostly mysterious implications for our health. But when something goes wrong, we defend ourselves with the undiscriminating brute force of traditional antibiotics, which wipe out everything at once, regardless of the consequences.

Attacking type 2 diabetes from a new direction with encouraging results

Type 2 diabetes affects an estimated 28 million Americans according to the American Diabetes Association, but medications now available only treat symptoms, not the root cause of the disease. New research from Rutgers shows promising evidence that a modified form of a different drug, niclosamide – now used to eliminate intestinal parasites – may hold the key to battling the disease at its source.

Contaminated water linked to pregnancy complications

Prenatal exposure to tetrachloroethylene (PCE) in drinking water may increase the risk of stillbirth and placental abruption, according to a new study led by a Boston University School of Public Health researcher.

Genetic secrets of the monarch butterfly revealed

The monarch butterfly is one of the most iconic insects in the world, best known for its distinct orange and black wings and a spectacular annual mass migration across North America. However, little has been known about the genes that underlie these famous traits, even as the insect's storied migration appears to be in peril.

A discovery could prevent the development of brain tumors in children

Montréal, October 2, 2014 – Scientists at the IRCM discovered a mechanism that promotes the progression of medulloblastoma, the most common brain tumour found in children. The team, led by Frédéric Charron, PhD, found that a protein known as Sonic Hedgehog induces DNA damage, which causes the cancer to develop. This important breakthrough will be published in the October 13 issue of the prestigious scientific journal Developmental Cell. The editors also selected the article to be featured on the journal's cover.

New study finds lack of adherence to safe handling guidelines for administration of antineoplastic drugs

FALLS CHURCH, Va. (October 3, 2014) — A new National Institute for Occupational Safety and Health (NIOSH) study, published online in the Journal of Occupational and Environmental Hygiene, found that recommended safe handling practices for workers who administer antineoplastic drugs in healthcare settings are not always followed.

Study questions the prescription for drug resistance

In response to the rise of drug-resistant pathogens, doctors are routinely cautioned against overprescribing antimicrobials. But when a patient has a confirmed bacterial infection, the advice is to treat aggressively to quash the infection before the bacteria can develop resistance.

Alcohol consumption associated with increased risk of HPV infection in men, say Moffitt researchers

Men who consume more alcohol have a greater risk of human papillomavirus (HPV) infection, according to a recent study by Moffitt Cancer Center researchers.

RCas9: A programmable RNA editing tool

A powerful scientific tool for editing the DNA instructions in a genome can now also be applied to RNA, the molecule that translates DNA's genetic instructions into the production of proteins. A team of researchers with Berkeley Lab and the University of California (UC) Berkeley has demonstrated a means by which the CRISPR/Cas9 protein complex can be programmed to recognize and cleave RNA at sequence-specific target sites. This finding has the potential to transform the study of RNA function by paving the way for direct RNA transcript detection, analysis and manipulation.

New study finds lack of adherence to safe handling guidelines for administration of antineopla

FALLS CHURCH, Va. (October 3, 2014) — A new National Institute for Occupational Safety and Health (NIOSH) study, published online in the Journal of Occupational and Environmental Hygiene, found that recommended safe handling practices for workers who administer antineoplastic drugs in healthcare settings are not always followed.

Experts recommend against diagnosing testosterone deficiency in women

Washington, DC—The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against the use of testosterone therapy in healthy women.